title: Serum albumin level in the management of postoperative enteric fistula for gastrointestinal cancer patients.
abstract: Postoperative enteric fistula is a serious complication and cause of death following gastrointestinal (GI)-tract surgery. Many reports have demonstrated the effectiveness of parenteral nutrition in the spontaneous closure of enteric fistula. Our study was aimed at analyzing the prognostic factors of parenteral nutritional support in the treatment of enteric fistula for patients with GI-tract cancer following surgery. GI-tract cancer patients receiving surgical interventions, which then unfortunately developed enteric fistula, were included in our study. All of them had to have received parenteral nutrition soon after leakages were recognized, and they were subsequently divided into successful and unsuccessful (classified as "failure") groups according to spontaneous closure of fistula or not, respectively. The studied patients' laboratory data were collected to identify the clinically relevant prognostic factors. Fifty-three primary GI-tract cancer patients with postoperative enteric fistulas were enrolled into our study. Of these, 33 patients were considered as successful parenteral nutritional therapy (successful group) and the other 20 patients (failure group) were not. After a period of parenteral nutritional therapy, serum total bilirubin, creatinine, C-reactive protein (CRP), hemoglobin, and albumin were significantly different between these two groups (all p < .05). Using a multivariate logistic regression analysis, it was determined that increased serum albumin level was an independent predictive factor of successful management for enteric fistula (p = .029), in addition to the well-known lower drainage amount (< 500 mL/day) from the enteric fistula (p = .013). Our observations show that both serum albumin levels and drainage amounts from the enteric fistula can be potentially used as important prognostic predictors of healing enteric fistula under total parenteral nutrition in patients following surgery for GI-tract malignancies.
authors.affiliation: Nutrition Support Team and Department of Internal Medicine, Kaohsiung Medical University Hospital, No. 100 Tzyou 1st Road, Kaohsiung, Taiwan.
authors.forename: Chien-Yu
authors.initials: CY
authors.lastname: Lu
authors.forename: Deng-Chyang
authors.initials: DC
authors.lastname: Wu
authors.forename: I-Chen
authors.initials: IC
authors.lastname: Wu
authors.forename: Koung-Shing
authors.initials: KS
authors.lastname: Chu
authors.forename: Li-Chu
authors.initials: LC
authors.lastname: Sun
authors.forename: Ying-Ling
authors.initials: YL
authors.lastname: Shih
authors.forename: Fang-Ming
authors.initials: FM
authors.lastname: Chen
authors.forename: Jan-Sing
authors.initials: JS
authors.lastname: Hsieh
authors.forename: Jaw-Yuan
authors.initials: JY
authors.lastname: Wang
mesh_terms: D000368:Aged; D016154:Digestive System Fistula / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy; D013505:Digestive System Surgical Procedures / Q000009:adverse effects*; D005260:Female; D005770:Gastrointestinal Neoplasms / Q000601:surgery; D006801:Humans; D008297:Male; D008875:Middle Aged; D010288:Parenteral Nutrition; D011379:Prognosis; D012709:Serum Albumin
chemical_list: D012709:Serum Albumin